Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ligand. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114436949B enables mild ester hydrogenation with high stability, reducing catalyst costs and improving supply chain reliability for fine chemical manufacturing.
Patent CN110615811A enables high-purity chiral ligand synthesis via crystallization method eliminating column chromatography thus reducing manufacturing costs and improving supply chain reliability.
Novel axial chiral phosphine-ene ligand enables high-yield asymmetric allylation with mild conditions, reducing manufacturing costs and lead times for fine chemicals.
Patent CN109053556A enables high-purity fine chemical synthesis with mild conditions, reducing lead time and manufacturing costs for complex catalyst ligands.
Discover how this novel chiral catalyst enables 99% ee synthesis with 90% yield, reducing R&D costs and supply chain risks for oncology drug development.
Discover how novel biphenyl-type tridentate ligand ruthenium complexes enable ester-to-alcohol hydrogenation at 60-100°C and 3-10MPa, reducing costs and safety risks for pharma production.
Solve low-yield C-H activation challenges with 94% yield & 92% ee. Scale to 100MT/yr with no byproducts. Contact for COA/MSDS.
Solve enantioselectivity challenges in asymmetric hydrogenation with tunable bisphosphine ligands. Achieve 92-99% ee, recyclable catalysts, and simplified synthesis for cost-effective API production.
Discover how novel axial chiral phosphine-ene ligands enable high-yield, enantioselective allyl substitutions with simplified manufacturing for pharma R&D and production.
Reduce production costs and avoid moisture-sensitive steps with this zirconium-based amide synthesis method. Ideal for pharmaceutical intermediates and large-scale manufacturing.
Solve C-S bond formation challenges with air-stable indole phosphine ligands. Achieve 90% yield at 0.5 mol% Pd loading. Scale to 100 MT/yr with NINGBO INNO PHARMCHEM.
Solve low-yield and high-cost carbamate synthesis challenges with nickel-catalyzed methods. Achieve 94.7% yields and simplified production for API manufacturing.
Solve aryl boronic acid synthesis challenges with thiosilane ligand: 80-86% yield, simplified purification, and industrial scalability for pharma intermediates.
Solve low yield and purification challenges in arylboronic acid synthesis. Our CDMO expertise scales thiosilane ligand technology for 99% purity and cost efficiency.
High-yield, high-ee synthesis of non-natural amino acids with water as proton source. Reduce production costs and supply chain risks for API manufacturing.
97% ee, >95% yield, low-cost industrial production of chiral alpha-hydroxy-beta-keto esters for agrochemicals. Solve supply chain risks with scalable zirconium catalysis.
Solve chiral ligand supply chain risks with this metal-free synthesis. 86% yield, no resolution needed. Contact for custom production.
Solve asymmetric synthesis challenges with novel chiral nitrogen-diene ligands. 99% yield, 90% ee, and water-tolerant processes reduce production costs for pharma R&D and manufacturing.
Solve asymmetric synthesis challenges with novel chiral nitrogen-diene ligands. 99% yield, 90% ee in rhodium-catalyzed reactions. Scale to 100 MT/annual with NINGBO INNO PHARMCHEM.
Eliminate chiral column costs with novel crystallization-based resolution. Achieve >99% ee and 76-78% yield for 6,6'-dihydroxy-5,5'-bisquinoline. Scale to 100MT/yr with NINGBO INNO PHARMCHEM's CDMO expertise.